Visceral Fat Doctor: The Fasting Reboot Protocol for Belly Fat and Insulin Resistance

Summary

A “metabolic reboot” versus optimization

Dr. John Schoeff distinguishes shorter fasting strategies intended to optimize an already functioning metabolism from a more intensive “reboot” for people with substantial metabolic dysfunction. He argues that fine-tuning may be less useful when the underlying system is severely impaired.

He says decisions should be based on objective measures, including fasting insulin, HOMA-IR, visceral-fat estimates, fatty-liver indicators, and muscle mass. Examples of markers he uses in his practice include fasting insulin above 15 and an InBody visceral-fat index above 10. These are his clinical criteria, not universal guidelines.

The fasting protocol described

In Schoeff’s practice, a reboot may involve fasting for up to three days, as often as every three weeks, depending on a person’s measurements and circumstances.

His approach, as described in the interview, includes:

• Using fasting as a tool, not a goal in itself. The intended aim is to improve metabolic health and measurable outcomes.
• Starting with a longer fast for some people he considers severely metabolically impaired, rather than gradually building up. He stresses that the fast should be something the person can repeat and complete.
• Using clinical support when needed. He argues that assistance may be appropriate if willpower or discomfort is preventing someone from achieving a health goal. The interview does not specify a standardized form of assistance.
• Tracking biological responses. The speakers discuss continuous glucose monitoring and ketone monitoring. Schoeff views rising ketones as a useful downstream sign that several fasting-related conditions are being met.
• Anchoring fasting to a gym schedule. Schoeff says resistance-training signals are important for stimulating or maintaining muscle, and that fasting plans in his practice are organized around exercise.
• Adjusting the plan to the individual. He emphasizes that the same fasting duration can affect people differently, especially when their baseline metabolic health differs.

This is a description of one clinician’s practice, not a general prescription for viewers.

Why fasting may feel difficult—and why glucose can stay elevated

The speakers describe a possible gap when someone shifts from relying mainly on carbohydrate metabolism toward using more fat and producing ketones. They say this transition can feel unpleasant, with symptoms such as shakiness, weakness, headaches, and strong food thoughts.

Schoeff suggests that some people may still have substantial stored fuel even when they feel hungry or unwell. He says that, in his experience, fasting glucose can remain elevated through multiple fasting sessions before it improves. He interprets persistent glucose as a sign of metabolic dysfunction, while acknowledging that the exact mechanisms may vary.

They discuss the liver as a central regulator of metabolism. During fasting, glucose can be produced through gluconeogenesis. The speakers discuss several possible sources, including glycerol released when triglycerides are broken down. They also note that gluconeogenesis is not simply synonymous with muscle being broken down: amino acids can contribute, but the speakers argue that fat-derived glycerol and other substrates also matter.

Calories in, calories out—and metabolic adaptation

The speakers agree that calorie restriction can produce results, but argue that focusing only on reducing food intake may be inefficient or difficult to sustain, particularly for people with more severe metabolic dysfunction. They describe plateaus as a form of metabolic adaptation and say a simple “eat less” approach may fail to address underlying issues such as insulin regulation, liver health, and fuel use.

They also discuss the limits of measuring “calories out.” The host argues that energy use depends on how effectively the body’s tissues and mitochondria use fuel. Their broader emphasis is on improving fuel utilization and physical activity, rather than focusing solely on eating less.

Hormones, exercise, and metabolic regulation

The discussion frames metabolism as a changing balance among interacting signals rather than a set of simple on/off switches. The speakers use “dials” and a “dance” as metaphors for this interaction.

They discuss AMPK, mTOR, insulin, and glucagon in the context of fasting, exercise, and cellular processes. Their view is that fasting and exercise can affect multiple pathways at once, and that these effects may be more useful when considered as part of an overall metabolic strategy.

Retatrutide and lipid management

Schoeff discusses retatrutide, describing it as a triple agonist that acts on GLP-1, GIP, and glucagon receptors. He focuses on glucagon’s role in counterbalancing insulin and presents the drug as a possible way to shift metabolic signaling. He cites trial results and a possible dose-related glucagon effect, but the conversation does not establish these as settled conclusions or provide detailed supporting evidence.

In a separate tangent, he argues that lipid management should be judged by health outcomes and relevant biomarkers, rather than treating one particular drug or mechanism as the only evidence-based route. LDL-C is discussed, with ApoB mentioned as a marker he expects to receive greater focus.

Visceral fat and urgency

Schoeff argues that reducing visceral fat and improving insulin regulation should be major priorities because he views visceral fat as metabolically harmful. The speakers use forceful metaphors, such as a “sledgehammer,” to convey their preference for stronger interventions when dysfunction is severe. They also acknowledge that intensive approaches may be challenging and that some people may not persist with them.

The guest makes broad claims about the prevalence and health risks of metabolic dysfunction. The host qualifies one statement about “90%” of Americans, noting that not everyone is technically insulin resistant and that metabolic health exists on a spectrum.

Sponsored segment

Thomas DeLauer includes a promotional segment for Thrive Market, describing it as an online grocery membership service and offering a discount and free gift. He says it can make it easier to stock a pantry with selected foods.

Speakers and sources featured

• Thomas DeLauer — Host and interviewer.
• Dr. John Schoeff — Guest physician discussing fasting and metabolic health; his name is inconsistently transcribed in the subtitles.
• Thrive Market — Sponsor featured in a promotional segment.

Mentioned but not speaking: Andrew Kubnik is referenced as a potential research collaborator. The speakers also refer generally to fasting research and clinical data without naming specific studies in the subtitles.